Member of the Board since december 2021.
Independent in relation to MedCap/major shareholders: Yes/Yes
Education: Master in Biochemistry and studies in economics from Chalmers, Uppsala University and Yale University.
Other current positions: CEO Alumbra Group. Chairman of the Board in Bioswed Scientific AB.
Previous positions (past five years): Long experience from management and strategic development in healthcare, pharmaceuticals and medical technology, various leading positions in medium-sized Swedish and international companies, such as CEO of Stille AB and Managing director of Tobi Churchill Ltd
Holdings: David Jern holds no shares in MedCap AB (publ)